Researchers from FAU and Sancilio and Company, Inc. are collaborating to develop a treatment for Retinitis Pigmentosa, an inherited disease that causes severe progressive vision impairment and blindness.
There is limited research and only anecdotal evidence suggesting that the public supports the use of body-worn cameras in policing. A new study reveals general public perceptions with some unexpected results.
Alana Edwards served on review panels to select applications submitted to the Department of Defense to decide how the $5 million appropriated by Congress will be spent on future tick-borne disease research.
Researchers from FAU and Harvard address the possible but unproven link between statins and diabetes and emphasize that the link to diabetes is questionable and inconsequential.
The first study to examine the effects of chair yoga on pain and physical function in older adults with osteoarthritis is proving to be an effective way to reduce pain and improve quality of life.
FAU will lead the Freight Mobility Research Institute to improve the nation's mobility of people and goods. A combined match from the state and private sectors will result in more than $10 million in total.
A new study at FAU is the first to demonstrate that the Parkin gene is turned on when cells are exposed to environmental insults that cause free radical formation and cataract formation.
Researchers in FAU's Christine E. Lynn College of Nursing conducted a unique study to explore how transplant recipients use social media sites for support and healing.
Janet Robishaw, Ph.D., a leader in functional and translational genomics, has been appointed as chair of the Department of Biomedical Sciences in FAU's Charles E. Schmidt College of Medicine.
FAU has entered into a licensing agreement with Neuro Pharmalogics, Inc., a biopharmaceutical company focused on developing and commercializing innovative therapies for patients with rare neurological diseases.